Shapely Blog

Constipation is one of the most common side effects of GLP-1 medications—sometimes more frustrating than nausea for people dealing with it. The good news? It's manageable. Understanding why GLP-1s slow your digestion and knowing which strategies actually work can help you feel more comfortable during your weight loss journey.

For many people on a weight loss journey, the idea of a daily pill instead of a weekly injection has been a long-awaited option. That option is now a reality because in December of 2025 the FDA approved Oral Wegovy®—making it the first and only oral GLP-1 medication approved specifically for weight management in adults. Oral Wegovy became available in January 2026 at most major pharmacies. Here’s what you need to know about how it works, what the research shows, and how it compares to the injectable version.

For years, the most talked-about weight-management medications came with one catch: a needle. This Summer, that changes for a lot of people. Foundayo™ (orforglipron), a once-daily pill in the same family as well-known treatments like semaglutide and tirzepatide is now available following its FDA approval in April 2026. The headline isn't just that it works. It's how easy it is to take.

For many Medicare beneficiaries, GLP-1 medications for weight loss have been out of reach — not because the medications don’t work, but because Medicare has historically not covered them for weight management. That’s changing. Beginning July 1, 2026, a new program called the Medicare GLP-1 Bridge will provide eligible Medicare Part D beneficiaries with access to GLP-1 medications approved for weight reduction at a $50 monthly copay (1). In this post, we’ll walk through what the GLP-1 Bridge is, who qualifies, which medications are included, and what you should know about costs and next steps.